Medsyn Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 53.95%
- Profit Growth 656.59%
- Ebitda 39.52%
- Net Worth 4.37%
- Total Assets 5.07%
About Medsyn Laboratories
Medsyn Laboratories Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 1999 and has a history of 25 years and ten months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vidyashankara Iyer, Gowri Sugantha, and Gowrishankara Iyer serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U02423KA1999PTC024895
-
Company No.
024895
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 1999
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Medsyn Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidyashankara Iyer
|
Additional Director | 15-Nov-2021 | Current |
|
Gowri Sugantha
|
Director | 12-Mar-1999 | Current |
|
Gowrishankara Iyer
|
Director | 12-Mar-1999 | Current |
Financial Performance of Medsyn Laboratories.
Medsyn Laboratories Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 53.95% increase. The company also saw a substantial improvement in profitability, with a 656.59% increase in profit. The company's net worth moved up by a moderate rise of 4.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medsyn Laboratories?
In 2018, Medsyn Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medsyn Therapeutics Private LimitedGowri Sugantha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medsyn Laboratories?
Unlock and access historical data on people associated with Medsyn Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medsyn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsyn Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
